AirSculpt Technologies, Inc. (AIRS)
NASDAQ: AIRS · Real-Time Price · USD
2.470
+0.020 (0.82%)
At close: Apr 28, 2026, 4:00 PM EDT
2.460
-0.010 (-0.40%)
After-hours: Apr 28, 2026, 4:17 PM EDT

Company Description

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.

The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.

It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.

In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas.

Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure.

Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

AirSculpt Technologies, Inc.
AirSculpt Technologies logo
Country United States
Founded 2012
IPO Date Oct 29, 2021
Industry Medical Care Facilities
Sector Healthcare
Employees 363
CEO Yogesh Jashnani

Contact Details

Address:
1111 Lincoln Road, Suite 802
Miami Beach, Florida 33139
United States
Phone 786 709 9690
Website airsculpt.com

Stock Details

Ticker Symbol AIRS
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $11.00
CIK Code 0001870940
CUSIP Number 009496100
ISIN Number US0094961002
Employer ID 87-1471855
SIC Code 8011

Key Executives

Name Position
Yogesh Jashnani Chief Executive Officer and Director
Michael J. Arthur Chief Financial Officer
Brent R. Wadman J.D. General Counsel
Stephanie Evans Greene Chief Marketing Officer

Latest SEC Filings

Date Type Title
Apr 21, 2026 SCHEDULE 13G/A Filing
Apr 16, 2026 ARS Filing
Apr 15, 2026 DEF 14A Other definitive proxy statements
Apr 6, 2026 8-K/A [Amend] Current report
Apr 6, 2026 10-K/A [Amend] Annual report
Apr 2, 2026 8-K Current Report
Mar 31, 2026 10-K Annual Report
Mar 16, 2026 SCHEDULE 13G/A Filing
Mar 16, 2026 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 16, 2026 8-K Current Report